Understanding how cancerous cells spread from a primary tumor is important for any number of reasons, including determining the aggressiveness of the disease itself.
A recent meta-analysis found that overall investigational drugs demonstrate modest survival benefits and greater toxicities for patients participating in cancer clinical trials.